Cathie Wood’s ARK Invest Sells Over 125,000 Shares of Iovance Bio

One of Cathie Wood's ARK Invest funds bought over 125,000 shares of Iovance Bio on August 25.

Published August 26, 2021, 8:45am ET · 1 min read

A gloved hand holds a luminous test tube containing a green leaf, surrounded by glowing hexagonal chemical structures and scientific symbols against a dark, gradient background fading from blue to green. The scene evokes scientific research and innovation.
Scientific research and pharmaceutical innovation, like those at Eli Lilly, are critical drivers of future growth. Advances in biotechnology are poised to unlock significant market value. © SergeyNivens / Getty Images

One of the ARK exchange-traded funds run by ETF star Cathie Wood made huge sale on Wednesday. This fund sold over 125,000 shares of Iovance Biotherapeutics Inc. (NASDAQ: IOVA | IOVA Price Prediction) shares, as the price of this ETF was flat on Wednesday. Note that this ETF is still up handily in the past year.

ARK Innovation ETF (NYSEARCA: ARKK) sold 128,163 shares of Iovance. At Wednesday’s closing price, this would have valued this sale at $3 million. Even though this is a small fraction of the total holdings, every little bit counts. The fund is up 37% in the past year.

Check out all of the ARK Invest sales for Wednesday:

Fund Ticker Name Shares
ARKF 3690HK MEITUAN 1,342,426
ARKF 9923HK YEAHKA 339,600
ARKF 6060HK ZHONGAN ONLINE P&C INSURANCE 1,339,400
ARKG SEER SEER 152,557
ARKG RHHBY ROCHE 66,000
ARKG PSTI PLURISTEM THERAPEUTICS 16,223
ARKG BMY BRISTOL-MYERS SQUIBB 114,400
ARKK IOVA IOVANCE BIOTHERAPEUTICS 128,163
ARKK NTDOY NINTENDO 53,300
ARKQ XONE EXONE 82,333
ARKW LC LENDINGCLUB 164,932
ARKW NFLX NETFLIX 192

[nativounit]
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
[recirclink id=941421][wallst_email_signup]

Contact [email protected] for any questions or corrections.

Chris Lange

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics. Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications. A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

All articles →